| Dr Jaimee Victoria Neben, MD | |
|
2478 N 72nd St, Wauwatosa, WI 53213-1204 | |
| (262) 391-8866 | |
| Not Available |
| Full Name | Dr Jaimee Victoria Neben |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 21 Years |
| Location | 2478 N 72nd St, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558435370 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 48360-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Enloe Medical Center | Chico, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northstate Anesthesiology Partners A Medical Corporation | 9234238809 | 23 |
News Archive
A large randomized trial comparing bypass surgery done with a heart-lung machine (on pump) and without it (off pump) found no differences in results between techniques overall but some clinically relevant differences, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
EntreMed, Inc. today announced that it completed a registered direct offering of 5,791,505 shares of its common stock, at a purchase price of $0.518 per share, to an existing accredited institutional investor. The sale resulted in gross proceeds to the Company of approximately $3 million. The terms of the purchase were set forth in a stock purchase agreement between the parties dated April 16, 2010. The per share purchase price reflects a 20% discount to the volume weighted average price on April 15, 2010.
Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.
On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein.
› Verified 2 days ago
| Entity Name | Northstate Anesthesiology Partners A Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639382336 PECOS PAC ID: 9234238809 Enrollment ID: O20070621000663 |
News Archive
A large randomized trial comparing bypass surgery done with a heart-lung machine (on pump) and without it (off pump) found no differences in results between techniques overall but some clinically relevant differences, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
EntreMed, Inc. today announced that it completed a registered direct offering of 5,791,505 shares of its common stock, at a purchase price of $0.518 per share, to an existing accredited institutional investor. The sale resulted in gross proceeds to the Company of approximately $3 million. The terms of the purchase were set forth in a stock purchase agreement between the parties dated April 16, 2010. The per share purchase price reflects a 20% discount to the volume weighted average price on April 15, 2010.
Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.
On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jaimee Victoria Neben, MD 2478 N 72nd St, Wauwatosa, WI 53213-1204 Ph: (262) 391-8866 | Dr Jaimee Victoria Neben, MD 2478 N 72nd St, Wauwatosa, WI 53213-1204 Ph: (262) 391-8866 |
News Archive
A large randomized trial comparing bypass surgery done with a heart-lung machine (on pump) and without it (off pump) found no differences in results between techniques overall but some clinically relevant differences, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session.
EntreMed, Inc. today announced that it completed a registered direct offering of 5,791,505 shares of its common stock, at a purchase price of $0.518 per share, to an existing accredited institutional investor. The sale resulted in gross proceeds to the Company of approximately $3 million. The terms of the purchase were set forth in a stock purchase agreement between the parties dated April 16, 2010. The per share purchase price reflects a 20% discount to the volume weighted average price on April 15, 2010.
Results from a 24-week phase 3 clinical study demonstrated that the investigational drug dapagliflozin, added to metformin, demonstrated significant mean reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c) and in the secondary endpoint, fasting plasma glucose (FPG) in patients with type 2 diabetes inadequately controlled with metformin alone, as compared to placebo plus metformin.
On November 20 at the American Society of Nephrology 43rd Annual Meeting, Columbia University Assistant Professor of Clinical Medicine Andrew Bomback, MD, presented results from a patient case series assessing the potential therapeutic value of H.P. Acthar Gel (repository corticotropin injection) as a treatment for patients with nephrotic syndrome, a kidney disorder characterized by excessive loss of urinary protein.
› Verified 2 days ago
Craig R Cook, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4025 N 92nd St, Wauwatosa, WI 53222 Phone: 414-358-5431 Fax: 414-358-5421 | |
William Jonathan Wood, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2643 N 113th St, Wauwatosa, WI 53226 Phone: 414-526-9683 | |
Maryam K Doyle, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10900 W Potter Rd, Wauwatosa, WI 53226 Phone: 414-774-9227 | |
Theresa M Richter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10900 W Potter Rd, Wauwatosa, WI 53226 Phone: 262-787-6737 Fax: 262-782-6040 | |
Omar Dyara, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 959 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-955-3955 | |
Dr. Shibani Bhattacharyya, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 11152 W Meinecke Ave, Apt #2, Wauwatosa, WI 53226 Phone: 804-878-0278 | |
Khalid Ghazi Al Abdul Raheem, B.S Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4025 N 92nd St, Wauwatosa, WI 53222 Phone: 414-358-5431 |